Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis | Zendy

Pierre D. Delmas | Zendy; Bernard Vrijens | Zendy; Richard Eastell | Zendy; Christian Roux | Zendy; Huibert A. P. Pols | Zendy; J. D. Ringe | Zendy; Andreas Grauer | Zendy; David L. Cahall | Zendy; Nelson B. Watts | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

Author(s) -

Pierre D. Delmas,

Bernard Vrijens,

Richard Eastell,

Christian Roux,

Huibert A. P. Pols,

J. D. Ringe,

Andreas Grauer,

David L. Cahall,

Nelson B. Watts

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-1526

Subject(s) - medicine , persistence (discontinuity) , bone remodeling , context (archaeology) , osteoporosis , hazard ratio , population , n terminal telopeptide , randomized controlled trial , vitamin d and neurology , prospective cohort study , confidence interval , paleontology , biochemistry , chemistry , alkaline phosphatase , geotechnical engineering , environmental health , osteocalcin , engineering , biology , enzyme

Persistence with osteoporosis treatment is poor but is important for maximum benefit.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research